PSPG alum Seibold appointed director of the NJH new Program in Regenerative Medicine and Genome Editing (REGEN)

The National Jewish Health (NJH) Office of Academic Affairs and the Center for Genes, Environment and Health has announced the creation of a Program in Regenerative Medicine and Genome Editing (REGEN) to be directed by Max A. Seibold, PhD. The overall mission of the program will be to advance regenerative medicine approaches for understanding the etiology of, and advancing potential therapies for, lung and immunological diseases. Initially, the REGEN program will focus on the establishment of stem cell techniques, including induced pluripotent stem cell (iPSC) derivation and experimentation at National Jewish Health. A main emphasis of the program will also be on the modification of disease genes and genetic variants in iPSCs for disease modeling and therapy. Seibold will name assistant directors for the program and engage the broader NJH community in seminars regarding the program in fall 2016.



About the School: The UCSF School of Pharmacy is a premier graduate-level academic organization dedicated to improving health through precise therapeutics. It succeeds through innovative research, by educating PharmD health professional and PhD science students, and by caring for the therapeutics needs of patients while exploring innovative new models of patient care. The School was founded in 1872 as the first pharmacy school in the American West. It is an integral part of UC San Francisco, a leading university dedicated to promoting health worldwide.